Free LSD!
Ceruvia Lifesciences to Supply LSD to Qualified Researchers at No Cost For qualified researchers only…
May 31, 2022
Ceruvia Lifesciences to Supply LSD to Qualified Researchers at No Cost For qualified researchers only…
MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program Tripping on ibogaine can last over
XPhyto provides progress update on Psychedelic Medicine Programs and Novel Compounds Milestone Vancouver, Canada, and
Blackhawk Subsidiary Digital Mind Technology Starts Phase 1 Development of Digital Therapeutic Platform and is
Take Two Shrooms and Call Me in the Morning: The Medical Promise of Magic Mushrooms
Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia SAN
PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status
Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Fibromyalgia San Diego, California–(Newsfile
Agtech and KRTL Biotech Join Forces to Develop and Distribute Unique CBD and Psilocybin Products
PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome Achieving
Psychedelics Could Be a Medical Game-Changer—So I Tried Them for My Debilitating Headaches Inspired by
TRYP THERAPEUTICS ANNOUNCES PLANS FOR PHASE 2A CLINICAL TRIAL FOR FIBROMYALGIA WITH THE UNIVERSITY OF
Magic mushrooms: UAB studying benefits for addiction and pain Dr. Peter Hendricks, a researcher at